Atlas Infectious Disease Practice

Welcome to Atlas Infectious Disease Practice, where your health and the well-being of the community are our top priorities. We take pride in our critical role in safeguarding public health by providing a comprehensive range of services focused on the diagnosis, treatment, management, and prevention of infectious diseases. Our dedicated team of physicians and healthcare professionals are committed to delivering expert care and guidance. Explore the services and affiliations that make us a trusted partner in your health journey

Mission Statement

At Atlas Infectious Disease Practice, we are dedicated to providing exceptional and compassionate care for patients in Palm Beach County and the surrounding areas. Our practice specializes in treating a wide range of infectious diseases, including HIV, tuberculosis, hepatitis, sexually transmitted infections, respiratory illnesses, and more.

As the leading infectious disease doctors near you, we utilize cutting-edge diagnostics and innovative treatments to enhance health outcomes and improve the quality of life for our patients. Our holistic approach focuses not only on treating current infections but also on preventing future ones. We are committed to personalized care, providing education and empowering our patients to actively manage their health.

Conveniently located in Palm Beach County, Atlas Infectious Disease Practice is your trusted partner in managing infectious diseases. Whether you’re seeking proactive Prevention or expert care from the best Infectious Disease Doctors near you, our team is here to help.

.

Services

Services Provided

Hospital Consultation

Office Consultation

Immigration Exams

Travel Consultation

Telemedicine

Yellow Fever Vaccine

HIV medicine

Sexually transmitted infection

employee health

IV infusion

Latest news

Stay Informed

Investigational Phage Therapy Shows Positive Topline Results for Diabetic Foot Osteomyelitis

Phage 3D imageImage credit: Victor Padilla-Sanchez, PhD Yesterday, an Israeli-based company, BiomX, announced results from its phase 2 trial studying its investigational phage therapy, BX211, which...

Infectious Disease Treatments on FDA’s Watchlist for Q2 2025

As we enter the second quarter of 2025, the FDA is reviewing treatments in infectious disease. Novavax is seeking full approval for its COVID-19 vaccine, Merck’s monoclonal antibody for RSV prevention...

Mpox could become a serious global threat, scientists warn

Mpox has the potential to become a significant global health threat if taken too lightly, according to scientists at the University of Surrey. In a letter published in Nature Medicine, researchers...

WHO Issues First Reports on Diagnostics, Therapies For Fungal Infections

Today, the World Health Organization (WHO) announced it had published 2 reports regarding therapies and diagnostics for fungal diseases. The reports were designed to address the gaps in testing and...

Humanizing Monoclonal Antibodies for Mucormycosis Treatment

Researchers have developed VX-01, a humanized monoclonal antibody designed to target mucormycosis, a severe fungal infection predominantly affecting immunocompromised individuals. VX-01 enhances the...

VX-01 Monoclonal Antibody Targets Mucormycosis by Blocking Angioinvasion

Researchers have developed VX-01, a humanized monoclonal antibody designed to target mucormycosis, a severe fungal infection predominantly affecting immunocompromised individuals. VX-01 enhances the...

With HHS Layoffs, What Becomes of Public Health?

This is the second in a series looking at the reduction and restructuring of federal health services and how that will affect public health and infectious disease clinical care. This past Friday, the...

Collaborative HCV Care with Pharmacists Could Address System-Level Treatment Barriers

Meghan Morris, PhD, MPH Credit: UCSF This news was originally posed on our sister site, HCPLive.com New research is shedding light on the importance of collaborative care for facilitating...

FDA Grants Marketing Authorization For First Home Test for STIs

Sexual transmitted infections (STIs) continue to be a public health concern. Along with millions of cases overall being diagnosed every year, attached to STIs is stigma and fear, which may prevent or...

Top 5 Infectious Disease News Stories Week of March 22-29

FDA Approves Gepotidacin (Blujepa) for Uncomplicated Urinary Tract Infections The FDA has approved gepotidacin (Blujepa), a new oral antibiotic for treating uncomplicated urinary tract infections...

Variability in Primary Care Telehealth Delivery Methods Across Chronic Conditions

This cross-sectional study examines chronic conditions that are more or less likely to be managed in...

HIV Viral Suppression With Long-Acting Antiretroviral Therapy

This study uses electronic medical record data to compare 48-week viral load outcomes after starting...

Unintentional Fentanyl Use Detected in Hair

This study assessed hair samples to detect fentanyl exposure among people with or at risk of HIV...

Comparative Bleeding Risk in Older Patients With HIV and Atrial Fibrillation Receiving Oral Anticoagulants

This cohort study compares the bleeding risks among warfarin, rivaroxaban, and apixaban users in a...

Hepatitis C Virus Screening in Pregnant and Nonpregnant Women After Universal Screening Guidelines

This study examines whether hepatitis C virus screening differs among pregnant and nonpregnant...

Changes to CDC’s Website Threaten Patients, Public Health

This Medical News article discusses the impact of President Donald Trump’s executive orders on the...

IAS-USA Recommendations: Antiretrovirals for Treatment and Prevention of HIV in Adults

This Special Communication from the International Antiviral Society–USA provides updated 2024...

Advances in Treatment and Prevention of HIV

Advances in antiretroviral therapy (ART) has led to HIV being a manageable and preventable condition...

Jarisch-Herxheimer Reaction After Benzathine Penicillin G Treatment for Early Syphilis

This secondary analysis of a randomized clinical trial assesses the incidence of Jarisch-Herxheimer...

Elective Surgery for People With HIV With Low CD4 Count

This case report describes a man in his 60s with hypertension, deep vein thrombosis, and a recent...

Communicable disease threats report, 22-28 March 2025, week 13

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 22-28 March 2025...

Communicable disease threats report, 15 – 21 March 2025, week 12

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 15 – 21...

Accepted insurances

Schedule appointment

We Are Dedicated To Your Health!

Better Care Starts With Us!

Testimonials

What Our Patients Say About Us!